132 related articles for article (PubMed ID: 3922631)
1. Lymphoma models for B-cell activation and tolerance. II. Growth inhibition by anti-mu of WEHI-231 and the selection and properties of resistant mutants.
Scott DW; Tuttle J; Livnat D; Haynes W; Cogswell JP; Keng P
Cell Immunol; 1985 Jun; 93(1):124-31. PubMed ID: 3922631
[TBL] [Abstract][Full Text] [Related]
2. Lymphoma models for B cell activation and tolerance. III. Cell cycle dependence for negative signalling of WEHI-231 B lymphoma cells by anti-mu.
Scott DW; Livnat D; Pennell CA; Keng P
J Exp Med; 1986 Jul; 164(1):156-64. PubMed ID: 3487612
[TBL] [Abstract][Full Text] [Related]
3. Lymphoma models for B cell activation and tolerance. V. Anti-Ig mediated growth inhibition is reversed by phorbol myristate acetate but does not involve changes in cytosolic free calcium.
Scott DW; Livnat D; Whitin J; Dillon SB; Snyderman R; Pennell CA
J Mol Cell Immunol; 1987; 3(2):109-20. PubMed ID: 3509921
[TBL] [Abstract][Full Text] [Related]
4. The regulation of growth and differentiation of a murine B cell lymphoma. II. The inhibition of WEHI 231 by anti-immunoglobulin antibodies.
Boyd AW; Schrader JW
J Immunol; 1981 Jun; 126(6):2466-9. PubMed ID: 6785356
[TBL] [Abstract][Full Text] [Related]
5. Lymphoma models for B cell activation and tolerance. I. Conditions for the anti-mu-dependent stimulation of growth in NBL, a nude B cell lymphoma.
Ling M; Livnat D; Pillai PS; Scott DW
J Immunol; 1985 Mar; 134(3):1449-54. PubMed ID: 2578509
[TBL] [Abstract][Full Text] [Related]
6. Lymphoma models for B cell activation and tolerance. IV. Growth inhibition by anti-Ig of CH31 and CH33 B lymphoma cells.
Pennell CA; Scott DW
Eur J Immunol; 1986 Dec; 16(12):1577-81. PubMed ID: 3493148
[TBL] [Abstract][Full Text] [Related]
7. Lymphoma models for B cell activation and tolerance. VI. Reversal of anti-Ig-mediated negative signaling by T cell-derived lymphokines.
Scott DW; O'Garra A; Warren D; Klaus GG
J Immunol; 1987 Dec; 139(12):3924-9. PubMed ID: 3500976
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of clonal abortion tolerogenesis. II. Clonal behaviour of immature B cells following exposure to anti-mu chain antibody.
Nossal GJ; Pike BL; Battye FL
Immunology; 1979 May; 37(1):203-15. PubMed ID: 112040
[TBL] [Abstract][Full Text] [Related]
9. Role of phosphoinositide-derived second messengers in mediating anti-IgM-induced growth arrest of WEHI-231 B lymphoma cells.
Page DM; DeFranco AL
J Immunol; 1988 Jun; 140(11):3717-26. PubMed ID: 2836499
[TBL] [Abstract][Full Text] [Related]
10. A mutant of the WEHI-231 B lymphocyte line that is resistant to phorbol esters is still sensitive to antigen receptor-mediated growth inhibition.
Haggerty HG; Monroe JG
Cell Immunol; 1994 Mar; 154(1):166-80. PubMed ID: 8118885
[TBL] [Abstract][Full Text] [Related]
11. Lymphoma models for B cell activation and tolerance. X. Anti-mu-mediated growth arrest and apoptosis of murine B cell lymphomas is prevented by the stabilization of myc.
Fischer G; Kent SC; Joseph L; Green DR; Scott DW
J Exp Med; 1994 Jan; 179(1):221-8. PubMed ID: 8270867
[TBL] [Abstract][Full Text] [Related]
12. Growth regulation of the B lymphoma cell line WEHI-231 by anti-immunoglobulin, lipopolysaccharide, and other bacterial products.
Jakway JP; Usinger WR; Gold MR; Mishell RI; DeFranco AL
J Immunol; 1986 Oct; 137(7):2225-31. PubMed ID: 3489760
[TBL] [Abstract][Full Text] [Related]
13. The influence of avidity on signaling murine B lymphocytes with monoclonal anti-IgM antibodies. Effects of B cell proliferation versus growth inhibition (tolerance) of an immature B cell lymphoma.
Udhayakumar V; Kumar L; Subbarao B
J Immunol; 1991 Jun; 146(12):4120-9. PubMed ID: 2040794
[TBL] [Abstract][Full Text] [Related]
14. Lymphoma models for B-cell activation and tolerance. IX. Efficient reversal of anti-Ig-mediated growth inhibition by an activated TH2 clone.
Alés-Martínez JE; Silver L; LoCascio N; Scott DW
Cell Immunol; 1991 Jul; 135(2):402-9. PubMed ID: 1828011
[TBL] [Abstract][Full Text] [Related]
15. Lymphoma models for B-cell activation and tolerance: anti-immunoglobulin M treatment induces growth arrest by preventing the formation of an active kinase complex which phosphorylates retinoblastoma gene product in G1.
Joseph LF; Ezhevsky S; Scott DW
Cell Growth Differ; 1995 Jan; 6(1):51-7. PubMed ID: 7718485
[TBL] [Abstract][Full Text] [Related]
16. Regulation of anti-immunoglobulin-induced B lymphoma growth arrest by transforming growth factor beta 1 and dexamethasone.
Gold MR; Gajewski TF; DeFranco AL
Int Immunol; 1991 Nov; 3(11):1091-8. PubMed ID: 1760404
[TBL] [Abstract][Full Text] [Related]
17. The synergistic effects of anti-IgM and monoclonal anti-Ia antibodies in induction of murine B lymphocyte activation.
Baluyut AR; Subbarao B
J Mol Cell Immunol; 1988; 4(1):45-57. PubMed ID: 3266924
[TBL] [Abstract][Full Text] [Related]
18. Role of B cells in the stimulation of syngeneic mixed lymphocyte responses.
Thorbecke GJ; Chapman-Alexander J; Katz IR; Bienenstock A; Asofsky R
Behring Inst Mitt; 1983 May; (72):107-16. PubMed ID: 6242330
[TBL] [Abstract][Full Text] [Related]
19. Anti-immunoglobulin antibodies induce apoptosis in immature B cell lymphomas.
Hasbold J; Klaus GG
Eur J Immunol; 1990 Aug; 20(8):1685-90. PubMed ID: 2209683
[TBL] [Abstract][Full Text] [Related]
20. Effects of mu-specific antibodies on B cell growth and maturation.
Leanderson T; Forni L
Eur J Immunol; 1984 Nov; 14(11):1016-21. PubMed ID: 6437843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
